(Q73011261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Geranylgeranylated RhoB is sufficient to mediate tissue-specific suppression of Akt kinase activity by farnesyltransferase inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

A Liu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G C Prendergast

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

481

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

205-208

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Farnesyltransferase inhibitors: antineoplastic mechanism and clinical prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Regulation of epidermal growth factor receptor traffic by the small GTPase rhoB

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

RhoB alteration is necessary for apoptotic and antineoplastic responses to farnesyltransferase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Inhibition of DNA synthesis by a farnesyltransferase inhibitor involves inhibition of the p70(s6k) pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Selective inhibition of ras-dependent transformation by a farnesyltransferase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Prenylation of RhoB is required for its cell transforming function but not its ability to activate serum response element-dependent transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

High-efficiency transformation of mammalian cells by plasmid DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Production of high-titer helper-free retroviruses by transient transfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Inhibition of farnesyltransferase induces regression of mammary and salivary carcinomas in ras transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Generation of protein-reactive antibodies by short peptides is an event of high frequency: implications for the structural basis of immune recognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

The phosphoinositide 3-OH kinase/AKT2 pathway as a critical target for farnesyltransferase inhibitor-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

PRK1 is targeted to endosomes by the small GTPase, RhoB

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

PDK1 acquires PDK2 activity in the presence of a synthetic peptide derived from the carboxyl terminus of PRK2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902003-2

10.1016/S0014-5793(00)02003-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11007964%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference